Quality Improvement Project to Increase Human Papillomavirus Two-Dose Vaccine Series Completion by 13  Years in Pediatric Primary Care Clinics

The human papillomavirus (HPV) causes genitourinary and oropharyngeal cancers. The HPV vaccine is safe and effective in preventing those diseases; however, vaccine series completion rates remain low in the United States. Our quality improvement (QI) project aimed to increase HPV-vaccination series completion rates to 70% from 2017 to 2020 for the 13-year patient population in an extensive academic pediatric primary care network that serves predominantly minority and Medicaid-insured children in Columbus, OH.
Source: Journal of Adolescent Health - Category: Child Development Authors: Tags: Original article Source Type: research